Ablative or fractional? The CO₂ distinction

Two words dominate CO₂ marketing — ablative and fractional — and they are routinely treated as alternatives, as though a platform is one or the other. They are not alternatives. They describe different things, and a treatment can be both.

This is not pedantry. It changes how you read a specification sheet.

Two different questions

Ablative or non-ablative answers: what happens to the tissue that receives energy?

Ablative delivery concentrates energy enough to vaporise tissue water at the surface — removing tissue. Non-ablative approaches deposit heat without removing tissue, an approach covered under controlled thermal remodeling.

Fractional or fully ablative answers a completely different question: what pattern is the energy delivered in?

Fractional delivery divides the beam into an array of microscopic zones, so a portion of the surface receives energy while tissue in between is left untreated. Fully ablative delivery treats the surface as a continuous area.

Combine the two axes and you get the modes a platform may offer — fully ablative across a continuous area, or fractional delivery of ablative zones. These are meaningfully different procedures.

Why the distinction has teeth

Read a specification sheet with those two axes in mind and the gaps become obvious:

• A sheet claiming “fractional” tells you about the coverage pattern and nothing about intensity.
• A sheet claiming “ablative” tells you about tissue interaction and nothing about coverage.

You need both figures to know what a platform actually does. A brochure that leads with one and stays quiet on the other has told you half the story — and it is worth noticing which half a supplier volunteers.

The specification that carries no information

Here is the one that catches buyers out. Every CO₂ platform emits at approximately 10,600 nm. It is a property of the carbon dioxide source, not a design choice.

So when a brochure leads with the wavelength, it is telling you the device category — not distinguishing the device. Wavelength is the least differentiating number on a CO₂ spec sheet, and it is frequently the most prominent.

The same goes for output power in isolation. It bounds what a platform can do without describing how precisely it does it.

Where CO₂ platforms genuinely differ

Because the wavelength is fixed, precision has to be engineered into the delivery — which is where real differences live.

The scanner is the hardware that places the pattern. The source produces energy; the scanner decides where each zone lands. Pattern options, how coverage is adjusted, and how consistently zones are placed are all properties of the scanning hardware.

This is why two CO₂ systems with comparable source specifications can feel quite different to operate. Placement consistency affects how predictable a pass is. Available patterns affect which areas the platform suits. Handpiece options affect what an operator can reach comfortably. None of that appears in a wavelength or wattage figure.

Questions that actually separate platforms

• Which delivery modes does it support — fully ablative, fractional, or both?
• Which pattern shapes and sizes does the scanner offer?
• How is coverage adjusted, and across what range?
• Which handpieces are supplied, and which cost extra?
• How is placement consistency maintained across a pass?

These are answerable from a specification sheet and a demonstration. They are also the questions least likely to be addressed in general marketing material, which tends to lead with the figures every device in the category shares.

The business question underneath

For a clinic owner, the ablative/fractional choice is not only clinical. It shapes how a session fits the schedule, what the aftercare conversation involves, and how the room turns over — which in turn shapes pricing and capacity.

A platform supporting more than one mode lets the provider match the approach to the case, which is generally why multi-mode systems cost more than single-mode ones. Whether that premium pays back depends on your case mix, and that is worth working out before the demonstration rather than during it.

Specific parameters are provider-directed and governed by training — not something to compare from a website. Specifications, licensing, and regulatory status for our CO₂ platform are on the Alexa CO₂ Aesthetic product page.

---

This article is general education for clinics and prospective buyers, not medical advice. Any treatment depends on the individual, their skin type, and a trained provider’s assessment.